Nasogastric Tube Holders Market Size, Share, and Growth Forecast 2026 - 2033

The global nasogastric tube holders market size is likely to be valued at US$206.8 million in 2026 and is estimated to reach US$358.4 million by 2033, growing at a CAGR of 8.2% during the forecast period from 2026 to 2033, driven by hospital initiatives to reduce device-related pressure injuries, the aging population's surging reliance on enteral nutrition, and the steady shift of long-term tube feeding into home care.

Driver - Pressure Injury Prevention Programs to Push Hospitals Toward Purpose-built Holders

Nasogastric tubes are a documented cause of medical device-related pressure injuries, and hospitals face increasing pressure to prevent them. Clinical research has identified nasogastric and endotracheal tubes as the two most common devices behind pressure injuries in intensive care, with nasogastric tubes responsible for a substantial share of device-related injuries in multi-center studies. These injuries range from nasal erosion to full-thickness tissue damage and are classified as largely preventable hospital-acquired conditions.

This clinical reality is changing procurement behavior. Facilities that once relied on standard adhesive tape are adopting purpose-built holders engineered to distribute tension and avoid pressure concentration at the nares. A 2026 nursing intervention study evaluating structured NGT-HAPI care guidelines found measurable improvement in pressure injury incidence following implementation, evidence increasingly cited in purchasing decisions.

Aging Population and Rising Enteral Nutrition Reliance to Boost Demand

Demographic change is expanding the base population requiring nasogastric feeding support. In the U.S. alone, an estimated 400,000 to 500,000 patients receive nasogastric tube placement annually across hospital, skilled nursing, and home settings, and market analysis attributes continued volume growth through 2035 to the aging population and improved survival among patients with neurological conditions requiring long-term enteral access.

Replacement frequency reinforces this driver further. Holders are typically changed every 24 to 72 hours in acute care and every three to seven days in long-term or home settings, creating a recurring consumption pattern per patient rather than a one-time purchase. As the treatable population grows, replacement cycles per patient rise alongside the base population itself.

Restraint - Adhesive-related Skin Reactions May Limit Extended Wear

Medical adhesive-related skin injury remains an unresolved side effect of adhesive securement, particularly in patients with fragile skin, including neonates, the elderly, and critically ill patients on long-term ventilation. Reactions range from mild erythema to skin stripping on removal, and manufacturers position newer designs around minimizing this risk rather than securement strength alone, signaling that adhesive tolerability constrains how long a holder can safely remain in place.

Device design adds a further complication. Finite element analysis comparing securement devices with and without hard plastic components found meaningful differences in tissue strain at the tube-skin interface, indicating rigid components in some designs can concentrate mechanical stress rather than distribute it. This creates a design trade-off between security and skin protection, slowing the case for switching an entire hospital formulary until comparative evidence is established.

Opportunity - Home Enteral Nutrition to Create a Recurring Consumer Channel

Enteral feeding management is shifting outside hospitals at a meaningful pace, with home care settings now representing a growing share of total consumption in mature markets such as North America. This shift changes the category's commercial profile, since a home-based patient becomes a repeat purchaser through pharmacy and direct-to-consumer channels rather than a single line item in a hospital's supply budget.

Manufacturers are already positioning products around this channel. Retail medical supply platforms now list feeding tube holders from multiple brands for home use, emphasizing adjustable fit, comfort during daily activity, and skin-friendly materials rather than acute-care performance alone. As home enteral nutrition populations grow alongside the aging demographic, this channel is positioned to grow faster than hospital-based procurement over the forecast period.

Neonatal and Pediatric-specific Design to Open a Differentiated Segment

Premature and neonatal patients have securement requirements distinct from the adult population, and improved survival rates among premature infants are expanding this segment specifically. Neonatal skin is thinner and more vulnerable to adhesive injury than adult skin, and tube sizing, nasal anatomy, and wear duration all differ from adult-focused design.

European specialists with established neonatal and pediatric lines have built a defensible position by designing for this population rather than adapting adult products downward. As neonatal intensive care capacity expands in regions with improving preterm survival, manufacturers with genuinely pediatric-engineered holders are positioned to capture share adult-first competitors cannot easily contest.

Product Type Insights

Adhesive tube holders are predicted to lead with a share of about 54.3% in 2026, as skin-barrier adhesive designs remain the default first-line securement method and are familiar to nursing staff already trained on their application and removal. These holders typically use a butterfly-shaped skin barrier that conforms to the patient's nose combined with a swivel or interlocking tab mechanism that secures the tube while limiting pressure on the nares, balancing security with a manageable skin injury risk for most patients.

Clip-based and strap-based holders are estimated to be a faster-growing format within the category, particularly for patients where extended wear or repeated adhesive application is impractical, such as those with sensitive or damaged skin. These designs shift the securement mechanism away from continuous adhesive contact, extending usable wear time in patients who would otherwise require unusually frequent changes, at some trade-off in application speed compared with adhesive alternatives.

End-User Insights

Hospitals are anticipated to dominate with a share of around 61.7% in 2026, asnasogastric tube placement remains concentrated in intensive care, post-surgical, and emergency settings, all within acute hospital care. Pressure injury prevention protocols, hospital-acquired condition reporting requirements, and centralized procurement reinforce hospital purchasing as the largest channel, and clinical evidence supporting specific holder designs is generated primarily in hospital research settings, anchoring adoption there first.

Home healthcare is expected to be the fastest-growing end-user, as enteral nutrition management continues shifting outside acute settings for long-term feeding support patients. Unlike hospital procurement, driven by clinical protocol and centralized purchasing, home healthcare demand is influenced by caregiver ease of use, comfort during daily activity, and retail availability, requiring a different commercial approach than the institutional sales model dominating hospital supply.

North America Nasogastric Tube Holders Market Trends

North America is predicted to dominate in 2026 globally with a share of approximately 38.6%, as the region combines high placement volumes with hospital reimbursement structures that financially penalize preventable hospital-acquired conditions, including device-related pressure injuries. This gives hospitals a direct financial incentive to standardize on securement devices with documented prevention performance, and the region also hosts the leading manufacturers and the deepest base of published comparative clinical evidence.

U.S. Nasogastric Tube Holders Market Trends

A share of nearly 87.2% is expected to be held by the U.S. in 2026 in North America, as it accounts for an estimated 400,000 to 500,000 placements annually and has the most developed hospital-acquired condition reporting framework globally. Market volume is projected to expand by roughly 30% to 50% over 2026 to 2035, driven by the aging population and improved survival among patients with neurological conditions requiring long-term enteral access, with higher-priced, skin-friendly systems outpacing unit volume growth.

Asia Pacific Nasogastric Tube Holders Market Trends

Asia Pacific is anticipated to be the fastest-growing region globally in 2026 with a share of around 24.1%, driven by rapid hospital infrastructure expansion across China and India alongside rising clinical awareness of enteral nutrition benefits among practitioners historically reliant on improvised tape-based securement. As intensive care and post-surgical bed capacity expands, placement volumes are rising from a comparatively low base, giving purpose-built holders room to displace standard tape more quickly than in already-established markets.

China Nasogastric Tube Holders Market Trends

China will likely lead in Asia Pacific in 2026 with a share of about 34.2%, supported by continued expansion of hospital critical care capacity and growing domestic manufacturing at price points accessible to hospitals beyond top-tier urban centers. Rising clinical training around hospital-acquired condition prevention is encouraging a shift from standard tape toward purpose-built holders, though tape remains common in lower-tier facilities where budget constraints favor the lowest-cost option.

India Nasogastric Tube Holders Market Trends

In 2026, India is projected to account for a share of just about 21.6% in Asia Pacific, as hospital infrastructure investment expands intensive care and neonatal capacity across both public and private healthcare systems. Increasing awareness of enteral nutrition benefits among clinicians is compounding this effect, particularly as neonatal survival rates improve, creating rising demand for appropriately sized pediatric and neonatal tube holders alongside the broader adult market.

Europe Nasogastric Tube Holders Market Trends

Europe will witness steady growth over the forecast period with a share of roughly 23.4% in 2026 globally, supported by an established base of intensive care and neonatal facilities and a strong regional presence of specialist manufacturers with dedicated pediatric and neonatal lines. European hospital systems have also generated a substantial share of the published comparative research on securement device design, giving regional procurement decisions an unusually strong evidence base.

Germany Nasogastric Tube Holders Market Trends

Germany is predicted to register a substantial regional share of approximately 25.8% in 2026, as it combines a large hospital sector with a healthcare system that reimburses evidence-based pressure injury prevention devices as standard inpatient care rather than an optional add-on. German neonatal intensive care capacity is also comparatively large, supporting steady demand for pediatric-specific holder designs alongside the adult market.

U.K. Nasogastric Tube Holders Market Trends

A share of nearly 18.9% is predicted to be held by the U.K. in 2026 in Europe, supported by National Health Service pressure ulcer prevention initiatives that have formally classified device-related pressure injuries as largely avoidable harm requiring documented protocols. This has pushed NHS trusts toward standardized, evidence-supported securement products over ad hoc tape methods, and centralized NHS procurement gives manufacturers with strong evidence a clearer path to national adoption.

The global nasogastric tube holders market is exceptionally consolidated, with a small number of established manufacturers accounting for most global volume. Dale Medical Products, Hollister, and Solventum, which continues 3M's legacy critical care securement portfolio, compete primarily on documented wear-time performance, skin tolerability, and ease of application, the attributes most directly tied to hospital purchasing decisions and reported pressure injury outcomes.

Distribution partners including Medline, Cardinal Health, and Tri-anim Health Services extend manufacturer reach into hospital group purchasing organizations and home healthcare channels, which matters where institutional procurement still accounts for most volume. Vygon and other specialists with dedicated neonatal and pediatric lines compete differently, positioning around age-appropriate design rather than the broader adult market.

Key Industry Developments

• In July 2026, Avanos Medical Australia received Australian registration for the Corgrip SR Tube Retention System, an intranasal nasogastric tube holder manufactured by Avanos Medical Inc. The TGA listed the device as a Class 1 medical device, indicating a new regulatory-market milestone for a dedicated nasogastric and nasointestinal tube retention system in Australia.
• In February 2026, researchers from Royal Adelaide Hospital, the University of South Australia, and the University of Adelaide published a pre-post study assessing routine nasal bridle use in acute stroke patients with nasogastric tubes. The study evaluated whether switching from conventional securement to nasal bridles could reduce tube dislodgement and improve nutritional delivery, adding clinical evidence for the use of dedicated tube-retention systems in dysphagic stroke patients.
• In June 2025, researchers published an analysis of FDA MAUDE reports examining complications associated with AMT nasal bridles. The analysis identified 24 unique adverse events reported between 2000 and 2023, including foreign-body retention, septal lacerations, skin irritation, and pressure necrosis. The study highlighted the need for proper placement and removal of nasal bridle systems as their use expands in hospital settings.